69 Best Pharma Startups to Watch in 2024
The Definitive Seedtable Ranking of Pharma Startups
We track 18,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
Our database reveals 275 cutting-edge startups in the Pharma industry, showcasing a vibrant ecosystem of innovation.
We've compiled profiles on 116 founders and executives for these startups, providing unparalleled access to key decision-makers.
Last update to the database: Sep 24, 2024. See changelog.
Displaying 69 out of 275 Companies
| Company | Score | Funding | Investors | Employees | Industries | Business Model | Location | Likely To Outsource | Contact | |
|---|---|---|---|---|---|---|---|---|---|---|
Pheon Therapeutics Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers. | 70 | $188M Series B | 4 | 11 to 50 | Pharma | London, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | c***s@pheontx.com | ||
Causaly Biomedical research discovery tool. | 60 | $78.2M Series B | 4 | 51 to 100 | Pharma | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | y*****s@causaly.com | ||
Apollo Therapeutics Portfolio of pharmaceutical research and discovery. | 60 | $33.5M Series C | 3 | 1 to 10 | Pharma | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | j************o@apollotherapeutics.com | ||
e-therapeutics Computational drug discovery platform. | 60 | $37.0M Series B | 1 | 11 to 50 | Pharma | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | a***********i@etherapeutics.co.uk | ||
Step Pharma Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1). | 56 | $59.7M Series B | 4 | 1 to 10 | Pharma | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | *****@step-ph.com | ||
Ariceum Therapeutics Diagnosis and treatment of hard-to-treat cancers. | 52 | $25.0M Series A | 4 | 11 to 50 | Pharma | Berlin, Germany | Marketing, Software Engineering, Marketing, Branding, Man... | g******n@ariceum-therapeutics.com | ||
Epsilogen Immuno-oncology company treats cancer with antibodies. | 52 | $44.2M Unknown | 3 | 11 to 50 | Pharma | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | t*m@epsilogen.com | ||
Hemab Treatments for genetic bleeding disorders. | 52 | $190M Series B | 2 | 1 to 10 | Pharma | Copenhagen, Denmark | Cybersecurity, Branding, Management Consulting, Sales, Hi... | t**a@hemab.com | ||
ImmunOs Therapeutics Immunotherapy platform for cancer. | 52 | $93.3M Unknown | 4 | 11 to 50 | Pharma | Zürich, Switzerland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | s********h@immunostherapeutics.com | ||
Manual Platform offering diagnostic tools and testing to aid patients in making health-related decisions. | 52 | $36.5M Series A | 3 | 11 to 50 | Pharma | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | g****e@manual.co | ||
Muna Therapeutics Therapies that slow or stop neurodegenerative diseases such as Alzheimer's and Parkinson's. | 52 | $75.4M Series A | 4 | Pharma | Copenhagen, Denmark | Hiring, Marketing, Software Engineering, Cybersecurity, B... | b**********n@munatherapeutics.com | |||
Peptone We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins. | 52 | $42.5M Series A | 2 | 11 to 50 | Pharma | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | k***l@peptone.io | ||
Precirix Manufacturer of radio-immunotherapeutic drugs for cancer patients. | 52 | $127M Series B | 7 | 11 to 50 | Pharma | Brussels, Belgium | Cybersecurity, Branding, Management Consulting, Sales, Hi... | r***********s@precirix.com | ||
ReViral Biotechnology firm developing antiviral treatments for patients. | 52 | $44.0M Series C | 2 | 11 to 50 | Pharma | London, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | |||
SafeHeal Solution for protecting digestive anastomosis, designed to reduce complications. | 52 | $47.6M Unknown | 1 | 1 to 10 | Pharma | Paris, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | c*********n@safeheal.com | ||
Synthace Platform for automating life sciences experiments and integrating the resulting data. | 52 | $35.0M Series C | 1 | 11 to 50 | Pharma | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | l*********h@synthace.com | ||
Calluna Pharma Developer of therapies for inflammatory and fibrotic diseases. | 52 | $81.7M Series A | 4 | 11 to 50 | Pharma | Oslo, Norway | Cybersecurity, Branding, Management Consulting, Sales, Hi... | j**********n@callunapharma.com | ||
Bactolife Producer of gut health binding proteins. | 48 | $41.2M Series A | 2 | 1 to 10 | Pharma | Copenhagen, Denmark | Marketing, Software Engineering, Marketing, Branding, Man... | s**q@bactolife.com | ||
Enterome Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases. | 48 | $127M Series F | 4 | 51 to 100 | Pharma | Paris, France | Design, Software Engineering, Sales, Marketing, Cybersecu... | p********d@enterome.com | ||
F2G Platform discovering and developing new drugs to treat severe fungal diseases. | 48 | $70.0M Unknown | 3 | 251 to 500 | Pharma | Manchester, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | f*****o@f2g.com | ||
Healx Platform for discovering new drugs for rare diseases using AI technology. | 48 | $56.0M Series B | 4 | 51 to 100 | Pharma | Cambridge, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | |||
ImCheck Therapeutics Platform developing new treatments that focus on the butyrophilin family's checkpoint molecules. | 48 | $102M Unknown | 4 | 11 to 50 | Pharma | Marseille, France | Cybersecurity, Branding, Management Consulting, Sales, Hi... | p*************x@imcheck.fr | ||
Inato AI-powered data collecting tool for clinical trials. | 48 | $21.6M Series A | 4 | 11 to 50 | Pharma | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | k*****h@inato.com | ||
NMD Pharma Treatment for severe neuromuscular disorders. | 48 | $165M Series B | 4 | 11 to 50 | Pharma | Aarhus, Denmark | Cybersecurity, Branding, Management Consulting, Sales, Hi... | j*g@nmdpharma.com | ||
Noema Pharma Clinical-stage central nervous system (CNS) technology. | 48 | $169M Series B | 3 | 1 to 10 | Pharma | Basel, Switzerland | Cybersecurity, Branding, Management Consulting, Sales, Hi... | i*******o@noemapharma.com | ||
Core Biogenesis Biotechnology platform developing advanced recombinant protein production technologies. | 44 | $14.2M Series A | 4 | 1 to 10 | Pharma | Paris, France | Design, Software Engineering, Sales, Marketing, Cybersecu... | a**************r@corebiogenesis.com | ||
GlycoEra Glycanengineering platform. | 44 | $49.3M Series A | 1 | 11 to 50 | Pharma | Zürich, Switzerland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | g**************a@glycoera.com | ||
Myricx Pharma Drug discovery platform focused on developing small molecule inhibitors. | 44 | $6.0M Seed | 1 | 1 to 10 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | r********r@myricxpharma.com | ||
Pear Bio Cancer treatment predictor software. | 44 | $15.2M Series A | 3 | 11 to 50 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | d****k@pearbio.com | ||
Flarin Patent-protected anti-inflammatory painkiller. | 44 | $6.3M Series A | 1 | 1 to 10 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | |||
Anjarium Biosciences Gene therapy research to tackle genetic diseases. | 43 | $59.5M Series A | 1 | 1 to 10 | Pharma | Zürich, Switzerland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | o************f@anjarium.com | ||
BioVersys Novel antiobiotic researcher to fight antimicrobial resistance. | 43 | $34.5M Series C | 2 | 1 to 10 | Pharma | Basel, Switzerland | Design, Software Engineering, Sales, Marketing, Cybersecu... | m************r@bioversys.com | ||
Castor EDC Cloud-based clinical data platform. | 43 | $63.3M Series B | 2 | 101 to 250 | Pharma | Amsterdam, Netherlands | Hiring, Marketing, Software Engineering, Cybersecurity, B... | j**e@castoredc.com | ||
MiNA Therapeutics Biotechnology company focused on developing therapeutic medicines by harnessing gene activation mechanisms. | 43 | $29.9M Unknown | 11 to 50 | Pharma | London, UK | Marketing, Software Engineering, Marketing, Branding, Man... | r****t@minatx.com | |||
ADmit Therapeutics Early detection of Alzheimer's disease (AD) technology. | 41 | $6.0M Series A | 3 | 1 to 10 | Pharma | Barcelona, Spain | Design, Software Engineering, Sales, Marketing, Cybersecu... | m*********a@admit-therapeutics.com | ||
CimCure Platform focused on designing and developing new active cancer immunotherapies. | 41 | $5.4M Seed | 1 | Pharma | Amsterdam, Netherlands | Design, Software Engineering, Sales, Marketing, Cybersecu... | d***********n@cimcure.com | |||
Kayentis Data capture for clinical trials. | 41 | $10.9M Seed | 1 | 11 to 50 | Pharma | Paris, France | Hiring, Design, Software Engineering, App Development, Ma... | g***e@kayentis.com | ||
Mablink Bioscience Biotechnology company developing advanced cancer treatments. | 41 | $34.9M Series A | 2 | 1 to 10 | Pharma | Lyon, France | Marketing, Software Engineering, Marketing, Branding, Man... | b******h@mablink.com | ||
Novair Medical Medical gas systems and oxygen generators designed, manufactured, and installed. | 41 | $30.6M Unknown | 1 | 101 to 250 | Pharma | , | Marketing, Software Engineering, Marketing, Branding, Man... | a*********d@novair.se | ||
Ochre Bio Biotechnology platform focused on rejuvenating transplant livers. | 41 | $39.8M Series A | 7 | 11 to 50 | Pharma | Oxford, UK | Marketing, Software Engineering, Marketing, Branding, Man... | q*******s@ochre-bio.com | ||
STipe Therapeutics Platform dedicated to harnessing the innate immune system to battle cancer. | 41 | $21.8M Series A | 2 | 1 to 10 | Pharma | Aarhus, Denmark | Marketing, Software Engineering, Marketing, Branding, Man... | |||
Beckley Psytech Short-duration psychedelic medicines developer for neuropsychiatric conditions. | 40 | $43.7M Series B | 2 | 1 to 10 | Pharma | Oxford, UK | Marketing, Software Engineering, Marketing, Branding, Man... | c***o@beckleypsytech.com | ||
Cardior Pharmaceuticals Platform for discovering and developing medicines to treat and prevent heart disease. | 40 | $76.0M Unknown | 5 | 11 to 50 | Pharma | Hanover, Germany | Hiring, Marketing, Software Engineering, Cybersecurity, B... | c*************h@cardior.de | ||
Eleva Biotechnology company that develops novel biological therapies. | 40 | $73.5M Unknown | 11 to 50 | Pharma | Freiburg, Germany | Hiring, Marketing, Software Engineering, Cybersecurity, B... | b*********s@elevabiologics.com | |||
Emergence Therapeutics Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need. | 40 | $99.3M Unknown | 2 | 1 to 10 | Pharma | Duisburg, Germany | Cybersecurity, Branding, Management Consulting, Sales, Hi... | j*****s@emergencetx.com | ||
Gesynta Pharma Developer of therapies for treating chronic inflammatory conditions. | 40 | $27.3M Series C | 2 | 1 to 10 | Pharma | Stockholm, Sweden | Marketing, Software Engineering, Marketing, Branding, Man... | p*************g@gesynta.se | ||
Immunocore Biotechnology company develops TCR bispecific immunotherapies. | 40 | $75.0M Series C | 251 to 500 | Pharma | Abingdon, UK | Hiring, Marketing, Software Engineering, Cybersecurity, B... | m***********g@immunocore.com | |||
Ona Therapeutics Therapeutic biologics platform to treat metastatic cancer. | 40 | $35.6M Series A | 2 | 1 to 10 | Pharma | Barcelona, Spain | Marketing, Software Engineering, Marketing, Branding, Man... | v*****e@ona-therapeutics.com | ||
OptiNose Nasal drug developer. | 40 | $99.1M Unknown | 5 | 101 to 250 | Pharma | Oslo, Norway | Hiring, Marketing, Software Engineering, Cybersecurity, B... | b**********i@optinose.com | ||
Osler Diagnostics Lab-quality diagnostics for anyone, anywhere, at any time. | 40 | $170M Unknown | 1 | 51 to 100 | Pharma | Oxford, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | d************n@oslerdiagnostics.com | ||
Oxford Nanopore Technologies Platform for analyzing single molecules like DNA, RNA, and proteins using nanopore-based electronic systems. | 40 | $275M Unknown | 1 | 251 to 500 | Pharma | Oxford, UK | Cybersecurity, Branding, Management Consulting, Sales, Hi... | g*************a@nanoporetech.com | ||
Pharvaris Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist. | 40 | $80.0M Series C | 11 to 50 | Pharma | Zug, Switzerland | Hiring, Marketing, Software Engineering, Cybersecurity, B... | b**********g@pharvaris.com | |||
Touchlight Distributed generation solutions enabling commercial property owners to self-generate electricity on-site. | 40 | $125M Unknown | 1 to 10 | Pharma | Brooklyn, US | Cybersecurity, Branding, Management Consulting, Sales, Hi... | s************i@tli.technology | |||
TreeFrog Therapeutics Stem cell company enabling access to cell therapies for millions of patients. | 40 | $82.3M Unknown | 1 | 11 to 50 | Pharma | Bordeaux, France | Hiring, Marketing, Software Engineering, Cybersecurity, B... | f****************s@treefrog.fr | ||
Iktos AI drug discovery platform. | 40 | $16.4M Series A | 1 | 11 to 50 | Pharma | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | n*****s@iktos.ai | ||
Abalos Therapeutics Developer of new immuno-virotherapies focused on treating cancer. | 37 | $63.0M Unknown | 3 | 11 to 50 | Pharma | Essen, Germany | Hiring, Marketing, Software Engineering, Cybersecurity, B... | k****a@abalos-tx.com | ||
Aignostics Platform that uses AI to improve diagnostics in pathology, aiding drug development and clinical research. | 37 | $19.9M Series A | 4 | 11 to 50 | Pharma | Berlin, Germany | Design, Software Engineering, Sales, Marketing, Cybersecu... | v****r@aignostics.com | ||
BC Platforms Platform offering tools to enhance the development of personalized and precision medicine. | 37 | $35.3M Unknown | 51 to 100 | Pharma | Zürich, Switzerland | Marketing, Software Engineering, Marketing, Branding, Man... | a******e@bcplatforms.com | |||
Biosyntia Biotech company specializing in synthetic biology and metabolic engineering. | 37 | $11.6M Series B | 1 | 11 to 50 | Pharma | Copenhagen, Denmark | Design, Software Engineering, Sales, Marketing, Cybersecu... | h*g@biosyntia.com | ||
Ermium Therapeutics Biotech firm developing treatments for auto-immune diseases. | 37 | $6.0M Series A | 1 | 1 to 10 | Pharma | Paris, France | Design, Software Engineering, Sales, Marketing, Cybersecu... | j*********t@ermium.com | ||
Lyphe group Supplier of medical cannabis care and medicine. | 37 | $6.2M Series A | 1 | 51 to 100 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | n**********s@lyphegroup.com | ||
Qubit Pharmaceuticals Platform that accelerates drug discovery using advanced computational techniques. | 37 | $17.2M Seed | 2 | 11 to 50 | Pharma | Paris, France | Marketing, Software Engineering, Marketing, Branding, Man... | r****t@qubit-pharmaceuticals.com | ||
Rappta Therapeutics Anti-cancer drugs ddevelopers activating protein phosphatase 2A (PP2A) | 37 | $10.5M Series A | 2 | 1 to 10 | Pharma | Helsinki, Finland | Design, Software Engineering, Sales, Marketing, Cybersecu... | s*************y@rappta-therapeutics.com | ||
Synklino Developer of a CMV-specific immunotoxin intended to eradicate cytomegalovirus infection. | 37 | $33.4M Series A | 1 | 1 to 10 | Pharma | Copenhagen, Denmark | Marketing, Software Engineering, Marketing, Branding, Man... | t*k@synklino.com | ||
Xund We enable healthcare companies to digitize patient interactions and translate data into actionable insights. | 37 | $2.2M Seed | 3 | 11 to 50 | Pharma | Vienna, Austria | Hiring, Design, Software Engineering, App Development, Ma... | p*******s@xund.ai | ||
Veratrak Supply chain platfrom for pharma. | 37 | $6.5M Series A | 11 to 50 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | a**************y@veratrak.com | |||
Phlo Digital pharmacy platform. | 37 | $12.2M Series A | 2 | 51 to 100 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | e***********m@wearephlo.com | ||
Actimed Therapeutics Developer of innovative treatment for muscle wasting disorders. | 37 | $7.7M Series A | 1 | 1 to 10 | Pharma | London, UK | Design, Software Engineering, Sales, Marketing, Cybersecu... | r****************e@actimedtherapeutics.com | ||
SOMAÍ Pharmaceuticals Developer of cannabinoid-containing pharmaceutical medicines. | 37 | $18.6M Series A | 11 to 50 | Pharma | Dublin, Ireland | Marketing, Software Engineering, Marketing, Branding, Man... | g***********w@somaipharma.eu |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.